These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16523307)

  • 1. Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis.
    Mahy P; De Bast M; Gillart J; Labar D; Grégoire V
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):553-6. PubMed ID: 16523307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.
    Mahy P; De Bast M; Leveque PH; Gillart J; Labar D; Marchand J; Gregoire V
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1263-72. PubMed ID: 15197503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.
    Mahy P; De Bast M; Gallez B; Gueulette J; Koch CJ; Scalliet P; Grégoire V
    Radiother Oncol; 2003 Apr; 67(1):53-61. PubMed ID: 12758240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
    Lee J; Siemann DW; Koch CJ; Lord EM
    Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
    Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
    Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
    J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
    Hoff MN; Yapp DT; Yung AC; Oliver TS; Kozlowski P
    Int J Radiat Biol; 2008 Mar; 84(3):237-42. PubMed ID: 18300024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
    Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
    Chitneni SK; Bida GT; Zalutsky MR; Dewhirst MW
    J Nucl Med; 2014 Jul; 55(7):1192-7. PubMed ID: 24854792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5.
    Matthews J; Adomat H; Farrell N; King P; Koch C; Lord E; Palcic B; Poulin N; Sangulin J; Skov K
    Br J Cancer Suppl; 1996 Jul; 27():S200-3. PubMed ID: 8763880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
    Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies.
    Woods ML; Koch CJ; Lord EM
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):93-101. PubMed ID: 12118570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia in human intraperitoneal and extremity sarcomas.
    Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
    Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
    J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.
    Bergeron M; Evans SM; Sharp FR; Koch CJ; Lord EM; Ferriero DM
    Neuroscience; 1999; 89(4):1357-66. PubMed ID: 10362320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
    Evans SM; Joiner B; Jenkins WT; Laughlin KM; Lord EM; Koch CJ
    Br J Cancer; 1995 Oct; 72(4):875-82. PubMed ID: 7547234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of changes in tumor hypoxia.
    Russell J; Carlin S; Burke SA; Wen B; Yang KM; Ling CC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1177-86. PubMed ID: 19251089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.